Welcome to EpilepsyU.com a social network dedicated to the epilepsy community

Cannabis Derived Medicine

Cannabidiol Is Effective Pediatric Add-On for Treatment-Resistant Epilepsy

For pediatric-onset treatment-resistant epilepsy, cannabinoids are effective as an adjunctive treatment for reducing seizure frequency by 50 percent or more, according to a review published online March 6 in the Journal of Neurology, Neurosurgery & Psychiatry. More effective than placebo for reducing seizure frequency, achieving seizure freedom.

BE EDUCATED ON CBD OIL – Hemp oil and CBD oil are drastically different cannabis products.

  While they are similar in some ways, there are important differences between hemp oil and CBD oil.  As a consumer, it’s easy to get confused by phrases such as “cannabis oil” and “marijuana oil,” especially when many companies seem to use these terms interchangeably. Let’s take a closer look at hemp oil and CBD oil to learn how to distinguish the two.   Hemp and marijuana are cousins in the plant world. Hemp oil and CBD oil come from different strains of the Cannabis sativa plant. However, hemp oil contains low levels of CBD – typically less than 25 parts per million – while CBD oil can be up to 15% CBD.   Because the plants are related, some unscrupulous sellers of hemp oil are trying to market it for its medicinal value, which is negligible.

Cannabidiol reduces seizures in treatment-resistant epilepsy

Cannabidiol is an effective and generally well-tolerated add-on treatment for drop seizures in patients with Lennox-Gastaut syndrome, according to research published in The Lancet. “Patients with Lennox-Gastaut syndrome, a rare, severe form of epileptic encephalopathy, are frequently treatment resistant to available medications,” Elizabeth A. Thiele, MD, from the pediatric epilepsy program at Massachusetts General Hospital, and colleagues wrote. “No controlled studies have investigated the use of cannabidiol for patients with seizures associated with Lennox-Gastaut syndrome.”

Yet More Good News for GW Pharma’s Cannabinoid Drug Against Epilepsy

New data in The Lancet provides further support for GW Pharma’s drug, Epidiolex, for the treatment of a rare form of epilepsy.   GW Pharmaceuticals has achieved encouraging Phase III results for Epidiolex, which have been published in leading scientific journal, The Lancet. The company’s lead candidate is being developed for the treatment of epilepsy – a condition characterized by the abnormal firing of neurons in the brain, leading to seizures. In particular, the company targets Lennox-Gastaut syndrome, a rare, lifelong form of epilepsy, which causes significant developmental delays.

New Research Into the Effectiveness of Cannabis for Autism

Scientists in Israel are conducting open clinical trials utilizing whole plant cannabis in search of an autism spectrum disorder treatment after stumbling upon a tremendous observation in an unrelated study.   Bonni Goldstein M.D., resident Marijuana.com medical expert and published author, said the early evidence shows autism is a result of genetic mutations and a deficit in the endocannabinoid system. Goldstein noted, “one case report and numerous anecdotal reports [have revealed] that cannabinoids may help some children with this disorder have better communication, less repetitive behaviors, less anxiety, and better social interaction.”

The World Health Organization Announcement About Cannabidiol Is Big News For People With Epilepsy, But More Research Needs To Be Done

Marijuana’s effect on the body has garnered more and more interest as it becomes legal for medical and recreational use in different states. People who are against marijuana legalization cite the potential for addiction and other dangerous side effects, but a new report may debunk this popularly-held belief. On Dec. 13, the World Health Organization (WHO) announced that a cannabis compound called cannabidiol (CBD) “could have therapeutic value” for epilepsy-related seizures. Additionally, the WHO says that CBD is not likely to be misused or create dependence, unlike other cannabis compounds like Tetra Hydro Cannabinol (THC).

Cannabis and Epilepsy Treatment

Since medicinal cannabis has become a more commonplace alternative for a well-established list of ailments, patients are finding a place for it next to their Advil and Tums. But unlike many other chronic illnesses that can be managed with over-the-counter supplements, epilepsy requires a specific cocktail of chemicals not readily available at the local corner store.

Study Finds Epilepsy Patients Feel Better After Daily CBD Regimen

WASHINGTON DC — Patients with intractable epilepsy in Alabama felt better overall one year after initiating a daily cannabidiol (CBD) regimen, according to a study presented here, despite also reporting declining social support and more stressful events over the course of the year.   Epilepsy patients started taking daily doses of CBD. One year later, a significant number felt better.   The state-funded study did not directly assess CBD’s impact. “I can’t say that” CBD was a factor, said lead researcher Barbara Hansen, now a sociology professor at Henderson State University (Arkansas). She did confirm that every patient in the study was indeed administered CBD, when she spoke to Leafly.com at the American Epilepsy Society annual meeting earlier in December.

Epilepsy Patients Failing Regular Meds Improved with Medical Cannabis

Reported better overall health as well as seizure control in pilot study Medically refractory epilepsy (MRE) patients in New York state who regularly used medical cannabis reported improvements in their health, according to a pilot survey presented here this week at the American Epilepsy Society annual meeting.

It’s ‘Buyer Beware’ When Purchasing Medical Pot Extract Online

People buying a medicinal marijuana extract over the internet often don’t get what they paid for, a new study warns.   Nearly 7 out of 10 cannabidiol (CBD) products tested did not contain the amount of marijuana extract promised on the label, researchers report.   “We wanted to see if they are accurately describing what is in their product,” said lead researcher Marcel Bonn-Miller.   “We found that generally speaking, no, they’re not. There are some people that are doing it right, but the majority of people in the industry are not,” said Bonn-Miller. He is an adjunct assistant professor of psychology in psychiatry at the University of Pennsylvania School of Medicine.

“A significant event”: CBD-based pharma drug Epidiolex presented to FDA for approval

A CBD-based pharmaceutical drug in development is one more step closer to potential FDA approval. Earlier this week, London-based GW Pharmaceuticals plc, which operates in the United States as Greenwich Biosciences, wrapped up its New Drug Application for Epidiolex, a formulation of the cannabis compound cannabidiol (CBD) for the treatment of seizures associated with two specific types of epilepsy: Lennox-Gastaut syndrome and Dravet syndrome.

What is CBD oil? Everything to know about the latest health trend

It’s a buzzy trend in the wellness world, and while CBD is one of the compounds found in the cannabis plant, don’t worry — it won’t get you high. Here’s what you need to know about the latest ingredient everyone’s talking about.   What is CBD? CBD is the abbreviation for cannabidiol, one of the many cannabinoids, or chemical compounds, found in marijuana and hemp. You’re probably already familiar with THC, which is another compound found in the cannabis plant. But unlike THC, CBD is not psychoactive. In other words, it’s not what gets you stoned. It’s also different from medical marijuana, which has been shown to reduce pain.

  • 1
  • 2
  • 9

Lost Password

Register